Impact of gut microbiota on liver transplantation
Copyright © 2023 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved..
The gut microbiota has been gaining attention due to its interactions with the human body and its role in pathophysiological processes. One of the main interactions is the "gut-liver axis," in which disruption of the gut mucosal barrier seen in portal hypertension and liver disease can influence liver allograft function over time. For example, in patients who are undergoing liver transplantation, preexisting dysbiosis, perioperative antibiotic use, surgical stress, and immunosuppressive use have each been associated with alterations in gut microbiota, potentially impacting overall morbidity and mortality. In this review, studies exploring gut microbiota changes in patients undergoing liver transplantation are reviewed, including both human and experimental animal studies. Common themes include an increase in Enterobacteriaceae and Enterococcaceae species and a decrease in Faecalibacterium prausnitzii and Bacteriodes, while a decrease in the overall diversity of gut microbiota after liver transplantation.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:23 |
---|---|
Enthalten in: |
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons - 23(2023), 10 vom: 01. Okt., Seite 1485-1495 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Sucu, Serkan [VerfasserIn] |
---|
Links: |
---|
Themen: |
Gut |
---|
Anmerkungen: |
Date Completed 03.10.2023 Date Revised 13.10.2023 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.ajt.2023.05.030 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM357790189 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM357790189 | ||
003 | DE-627 | ||
005 | 20231226073343.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.ajt.2023.05.030 |2 doi | |
028 | 5 | 2 | |a pubmed24n1192.xml |
035 | |a (DE-627)NLM357790189 | ||
035 | |a (NLM)37277064 | ||
035 | |a (PII)S1600-6135(23)00518-X | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Sucu, Serkan |e verfasserin |4 aut | |
245 | 1 | 0 | |a Impact of gut microbiota on liver transplantation |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 03.10.2023 | ||
500 | |a Date Revised 13.10.2023 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2023 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved. | ||
520 | |a The gut microbiota has been gaining attention due to its interactions with the human body and its role in pathophysiological processes. One of the main interactions is the "gut-liver axis," in which disruption of the gut mucosal barrier seen in portal hypertension and liver disease can influence liver allograft function over time. For example, in patients who are undergoing liver transplantation, preexisting dysbiosis, perioperative antibiotic use, surgical stress, and immunosuppressive use have each been associated with alterations in gut microbiota, potentially impacting overall morbidity and mortality. In this review, studies exploring gut microbiota changes in patients undergoing liver transplantation are reviewed, including both human and experimental animal studies. Common themes include an increase in Enterobacteriaceae and Enterococcaceae species and a decrease in Faecalibacterium prausnitzii and Bacteriodes, while a decrease in the overall diversity of gut microbiota after liver transplantation | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 4 | |a gut | |
650 | 4 | |a liver transplantation | |
650 | 4 | |a microbiota | |
650 | 4 | |a outcome | |
650 | 4 | |a rejection | |
650 | 7 | |a Immunosuppressive Agents |2 NLM | |
700 | 1 | |a Basarir, Kerem E |e verfasserin |4 aut | |
700 | 1 | |a Mihaylov, Plamen |e verfasserin |4 aut | |
700 | 1 | |a Balik, Emre |e verfasserin |4 aut | |
700 | 1 | |a Lee, Jason T C |e verfasserin |4 aut | |
700 | 1 | |a Fridell, Jonathan A |e verfasserin |4 aut | |
700 | 1 | |a Emamaullee, Juliet A |e verfasserin |4 aut | |
700 | 1 | |a Ekser, Burcin |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons |d 2001 |g 23(2023), 10 vom: 01. Okt., Seite 1485-1495 |w (DE-627)NLM119667924 |x 1600-6143 |7 nnns |
773 | 1 | 8 | |g volume:23 |g year:2023 |g number:10 |g day:01 |g month:10 |g pages:1485-1495 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.ajt.2023.05.030 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 23 |j 2023 |e 10 |b 01 |c 10 |h 1485-1495 |